Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:14 pm Sale | 2024-12-31 | 13G | Celcuity Inc. CELC | COMMODORE CAPITAL LP | 1,095,650 2.900% | -1,122,332 (-50.60%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | Celcuity Inc. CELC | BAKER BROS. ADVISORS LP | 2,678,553 7.200% | 803,575 (+42.86%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | Celcuity Inc. CELC | Perceptive Advisors LLC | 2,362,279 6.400% | 880,979 (+59.47%) | Filing History |
| 2025-02-11 4:00 pm Purchase | 2024-12-31 | 13G | Celcuity Inc. CELC | Soleus Capital Master Fund, L.P. | 3,872,184 9.900% | 1,248,294 (+47.57%) | Filing History |
| 2025-02-04 3:45 pm Purchase | 2024-12-31 | 13G | Celcuity Inc. CELC | BlackRock Inc. BLK | 2,179,064 5.900% | 2,179,064 (New Position) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Celcuity Inc. CELC | Venrock Healthcare Capital Partners III, L.P. | 0 0.000% | -2,476,980 (Position Closed) | Filing History |
| 2024-11-14 5:46 pm Unchanged | 2024-09-30 | 13G | Celcuity Inc. CELC | RA Capital Management, L.P. | 1,286,960 3.400% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:26 pm Purchase | 2024-09-30 | 13G | Celcuity Inc. CELC | BAKER BROS. ADVISORS LP | 1,874,978 5.100% | 1,874,978 (New Position) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | Celcuity Inc. CELC | COMMODORE CAPITAL LP | 2,217,982 5.900% | -274,904 (-11.03%) | Filing History |
| 2024-11-14 3:35 pm Purchase | 2024-09-30 | 13G | Celcuity Inc. CELC | Soleus Private Equity Fund II L.P. | 3,931,800 9.900% | 3,931,800 (New Position) | Filing History |
| 2024-10-07 4:26 pm Sale | 2024-09-30 | 13G | Celcuity Inc. CELC | MORGAN STANLEY MS | 1,391,552 3.800% | -803,474 (-36.60%) | Filing History |
| 2024-06-10 5:01 pm Purchase | 2024-05-30 | 13G | Celcuity Inc. CELC | BIOTECHNOLOGY VALUE FUND L P | 3,466,000 9.900% | 3,466,000 (New Position) | Filing History |
| 2024-02-14 8:28 pm Purchase | 2023-12-31 | 13G | Celcuity Inc. CELC | Venrock Healthcare Capital Partners III, L.P. | 2,476,980 9.990% | 2,476,980 (New Position) | Filing History |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | Celcuity Inc. CELC | RA Capital Management, L.P. | 1,286,960 5.000% | -962,461 (-42.79%) | Filing History |
| 2024-02-14 4:34 pm Purchase | 2023-12-31 | 13G | Celcuity Inc. CELC | Perceptive Advisors LLC | 1,481,300 6.100% | 40,000 (+2.78%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | Celcuity Inc. CELC | COMMODORE CAPITAL LP | 2,492,886 9.900% | 235,474 (+10.43%) | Filing History |
| 2024-02-12 11:55 am Purchase | 2023-12-31 | 13G | Celcuity Inc. CELC | MORGAN STANLEY MS | 2,195,026 9.100% | 1,103,185 (+101.04%) | Filing History |
| 2024-02-09 10:32 am Purchase | 2023-12-31 | 13G | Celcuity Inc. CELC | Soleus Capital Master Fund, L.P. | 2,623,890 9.900% | 338,336 (+14.80%) | Filing History |
| 2024-02-07 5:15 pm Purchase | 2023-12-31 | 13G | Celcuity Inc. CELC | Laing Lance G. | 1,421,036 5.500% | 47,289 (+3.44%) | Filing History |
| 2024-02-07 5:15 pm Purchase | 2023-12-31 | 13G | Celcuity Inc. CELC | Sullivan Brian F. | 3,648,665 14.000% | 168,385 (+4.84%) | Filing History |